Johnson & Johnson (JNJ) Investor Brief
A halal-compliant screen, a rebuild-style profile, and a mixed return picture.
At this stage, Johnson & Johnson seems like a selective rather than automatic idea, where investors may want clearer confirmation before treating it as a high-conviction holding.
Move through the brief chapter by chapter, from Halal screening and business direction to return interpretation and the final takeaway.
Johnson & Johnson (JNJ) sits at the intersection of business quality, Halal screening, and return potential, which makes it a good candidate for a shorter brief built around the signals non-specialist investors care about first. Johnson & Johnson is currently assessed as halal compliant, and the business profile presently reads as recovery or rebuild when the growth and maturity signals are considered together.
How to think about stocks
Get occasional insight on how to evaluate stocks, not just what stock to look at next. We write when there is something genuinely useful to add.
By subscribing, you agree to receive this optional email and can withdraw consent later. Read the privacy policy.
At a Glance
Johnson & Johnson is currently being reviewed as a healthcare company. Its market capitalization sits around 538.0B USD. The latest EBIT margin is about 35.6%. The indicated dividend yield is roughly 2.5%.
The maturity side looks better developed than the growth side, with growth score at about 1.8 out of 4 and maturity score around 3.2 out of 4, which can describe a company that has a base to work from but still needs a stronger expansion engine. Resilience is present, though only in a moderate way, which matters for investors who care about downside discipline. The cleaner support currently comes from Price Risk and Risk Exposure, and the resilience score itself sits around 3.2 out of 5.
Is JNJ Stock Halal?
Johnson & Johnson is currently assessed as halal compliant. It operates in a Halal-compliant industry. The next-year compliance read suggests Johnson & Johnson is expected to remain compliant within the coming year.
On the financial screen, interest income is around 1.12% versus the AAOIFI threshold of 5.00%, debt is around 9.53% versus the AAOIFI threshold of 30.00%, securities is around 7.34% versus the AAOIFI threshold of 30.00%. These thresholds follow AAOIFI-based screening standards used in purepofo’s methodology. The ratio profile presently supports the Halal classification without looking especially fragile.
| Financial ratio | Current level | Threshold |
|---|---|---|
| Interest Income | 1.12% | 5.00% |
| Debt | 9.53% | 30.00% |
| Securities | 7.34% | 30.00% |
What Does Johnson & Johnson Do?
Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
The maturity side looks better developed than the growth side, with growth score at about 1.8 out of 4 and maturity score around 3.2 out of 4, which can describe a company that has a base to work from but still needs a stronger expansion engine.
Margin Trend, Profitability Trend, Profit Stability and Dividend Trend provide much of the support for the current profile, but Reinvestment Capacity and Risk-Adjusted Returns keep the interpretation from looking fully one-sided.
Return Snapshot: JNJ 1-Year, 3-Year, and 5-Year ROI
For many retail investors, return history is the easiest entry point into the investment case, but it is still more useful when the pattern is interpreted rather than simply listed. The latest 1-year ROI is +46.8%. The trailing 3-year compounded ROI is +55.0%. The longer 5-year compounded ROI is +54.3%.
This is not a flat return story, but neither is it a cleanly directional one. The stock’s Sharpe profile suggests the quality of performance has been as notable as the scale of performance.
The available analyst target stands near 252.87 USD against about 222.96 USD today, which points to around +13% based on 24 analyst estimates. Investors should read that as sentiment context rather than certainty.
What Looks Good and Which JNJ Risks to Watch
The balance of positives is led by a rewarding longer-term return record and margin trend and profitability trend.
The main watch items are regulatory dependency, supply chain concentration, and esg controversy.
Bottom Line: Is JNJ a Good Stock to Buy?
At this stage, Johnson & Johnson seems like a selective rather than automatic idea, where investors may want clearer confirmation before treating it as a high-conviction holding.
Use the investor brief as a starting point, then continue into the broader purepofo research workflow when you want deeper methodology, screening, or comparative context.
If you want a more detailed, institutional-style version of this analysis, you can open the deeper stock review in purepofo advisor, which opens as a separate research experience in a new tab.
This article is provided for informational and educational purposes only. It does not constitute investment, legal, tax, Shariah, or other professional advice, and it is not a recommendation or solicitation to buy, sell, or hold any security. The content is general in nature, is not tailored to your personal circumstances or objectives, and should not be relied on as the sole basis for any investment decision.
Halal assessments, ratings, forecasts, and classifications reflect purepofo's methodology at the time of publication. They may change as company fundamentals, market data, methodology inputs, AAOIFI-based screening interpretations, or other information change. Proprietary scores and forward-looking assessments are inherently uncertain and are not guaranteed to be accurate, complete, or timely.
Third-party data may be used. purepofo does not guarantee the accuracy, completeness, or timeliness of third-party information and is not responsible for errors, omissions, or content provided by others. Logos and trademarks remain the property of their respective owners and are used for identification only.
You should carry out your own research and, where appropriate, consult qualified financial, legal, tax, and Shariah advisers before making any decision. Please also review our Terms and Conditions.
powered by innovation.
© 2026 purepofo.
All rights reserved.
Follow us on
